{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":23,"n_cols":5,"rows_kept":23,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[7,2,7,3],[8,2,8,3],[10,2,10,3],[12,2,12,3],[13,2,13,3],[16,2,16,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910784598403321"]
[null,null,"Autore",null,"Vardanyan Ṛuben"]
[null,null,"Titolo",null,"Synthesis of essential drugs / / Ṛ. S. Vardanyan, V. J. Hruby"]
[null,null,"Pubbl/distr/stampa",null,"Amsterdam ; ; London : , : Elsevier, , 2006"]
[null,null,"ISBN",null,"1-280-64180-0"]
[{"$nulls":4},"9786610641802"]
[{"$nulls":4},"0-08-046212-X"]
[null,null,"Descrizione fisica",null,"1 online resource  (xvi, 617 pages) : illustrations"]
[null,null,"Disciplina",null,"615.19"]
[{"$nulls":4},"615.7"]
[null,null,"Soggetti",null,"Pharmaceutical chemistry"]
[{"$nulls":4},"Drugs - Design"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"front cover; copyright; front matter; Preface; table of contents; body; General Anesthetics; Inhalation Anesthetics; Noninhalation Anesthetics; Local Anesthetics; Local Anesthetics of the Aminoether Series; Local Anesthetics of the Aminoamide Series; Topical Anesthetics; Analgesics; Opioid Analgesics; Agonists; Mixed agonists/antagonists; Opioid antagonists; Nonsteroid Anti-Inflammatory Drugs and Anti-Fever Analgesics; Salicylic acid derivatives; Pyrazolonees; p-Aminophenol derivatives; Anthranylic acid derivatives; Propionic acid derivatives; Acetic acid derivatives"]
[{"$nulls":4},"Indolyl/indeneacetic acids; Oxicames; Soporific Agents (Hypnotics and Sedative Drugs); Barbiturates; Long-acting barbiturates; Intermediate-acting barbiturates; Short-action barbiturates; Ultrashort-action barbiturates; Benzodiazepines; Other Hypnotics and Sedative Drugs; Anxiolytics (Tranquilizers); Benzodiazepines; Anxiolytic of Nonbenzodiazepine Structures; Antipsychotics (Neuroleptics); Phenothiazine Derivatives; Thioxanthene Derivatives; Butyrophenone Derivatives; Dihydroindolone Derivatives; Dibenzoxazepine and Dibenzdiazepine Derivatives; Diphenylbutylpiperidine Derivatives"]
[{"$nulls":4},"Other Neuroleptics; Lithium Derivatives; Antidepressants; Tricyclic Antidepressants; Tertiary amines-representatives of tricyclic antidepressants; Secondary amines-representatives of tricyclic antidepressants; Monoaminooxidase Inhibitors; Second-Generation Antidepressants (Atypical Antidepressants); Amphetamines and Other "]
[{"$nulls":4},"CNS Stimulators; Central Nervous System Stimulants; Psychomotor Stimulants; Methylxanthines; Amphetamines, methylphenidate, and pemoline; Respiratory Stimulants or Analeptics; Appetite Suppressants or Anorectics; Antiepileptic Drugs; Hydantoin Derivatives; Barbiturates"]
[{"$nulls":4},"Succinimides; Valproic Acid; Carbamazepine; Benzodiazepines; Acetazolamide; Oxazolidines; Antiparkinsonian Drugs; Drugs Affecting the Dopaminergic Systems of the Brain; Anticholinergic Drugs (Central Cholinoblockers); Adrenergic (Sympathomimetic) Drugs; Direct-Acting Agonists; Drugs stimulating α- and β-adrenoreceptors; Drugs stimulating predominantly β-adrenoreceptors; Drugs stimulating predominantly α-adrenoreceptors; Antiedema sympathomimetics; Indirect-Acting Agonists; Agonists of Mixed Action; Adrenoblocking Drugs; β-Adrenoblockers; α-Adrenoblockers; Long-lasting noncompetitive antagonists"]
[{"$nulls":4},"Nonselective, reversible competitive adrenoblockers; Reversible, competitive α1-selective adrenoblockers; Ergot alkaloids (alkaloids of ergot); Selective α2-adrenoblockers; Adrenergic Neuron Blockers; Cholinomimetics; Direct-Acting Cholinomimetics; Choline esters; Natural muscarinic alkaloids; Natural nicotinic alkaloids; Indirect-Acting Cholinomimetics; Reversible cholinesterase inhibitors; Carbamates; Quaternary amines; Irreversible cholinesterase inhibitors; Other organophosphorous cholinesterase inhibitors; Anticholinergic Drugs; Antimuscarinic Drugs; Alkaloids; Anticholinergics of the quaternary amine series"]
[null,null,null,"Sommario/riassunto","This book represents an effort to express a long overdue need of compiling information which has been accumulated over the course of more than 30 years of our work in the area of the synthesis of medicinal drugs.  Our effort fills obvious gaps that exist in the literature of drug synthesis. The synthesis of various groups of drugs are presented in an order similar to that  traditionally presented in a pharmacology curriculum.  This was done with a very specific goal in mind - to harmonize the chemical aspects with the pharmacology curriculum in a manner useful to chemists."]